Virtu Financial LLC Buys New Stake in Quantum-Si Incorporated $QSI

Virtu Financial LLC bought a new stake in Quantum-Si Incorporated (NASDAQ:QSI) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 34,830 shares of the company’s stock, valued at approximately $42,000.

Several other hedge funds also recently modified their holdings of QSI. Geode Capital Management LLC increased its position in shares of Quantum-Si by 2.2% during the 4th quarter. Geode Capital Management LLC now owns 2,368,376 shares of the company’s stock valued at $6,395,000 after purchasing an additional 51,455 shares during the period. Wells Fargo & Company MN increased its position in shares of Quantum-Si by 13.9% during the 4th quarter. Wells Fargo & Company MN now owns 71,980 shares of the company’s stock valued at $194,000 after purchasing an additional 8,802 shares during the period. Renaissance Technologies LLC increased its position in shares of Quantum-Si by 1,211.4% during the 4th quarter. Renaissance Technologies LLC now owns 544,956 shares of the company’s stock valued at $1,471,000 after purchasing an additional 503,400 shares during the period. Mariner LLC increased its position in shares of Quantum-Si by 29.1% during the 4th quarter. Mariner LLC now owns 33,439 shares of the company’s stock valued at $90,000 after purchasing an additional 7,540 shares during the period. Finally, Jump Financial LLC acquired a new position in shares of Quantum-Si during the 4th quarter valued at $33,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently issued reports on QSI. HC Wainwright reiterated a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a research report on Monday, May 19th. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research report on Friday, May 16th.

Quantum-Si Stock Down 0.9%

QSI opened at $1.09 on Tuesday. The firm has a market cap of $220.71 million, a PE ratio of -1.60 and a beta of 2.87. The business has a fifty day simple moving average of $1.68 and a 200-day simple moving average of $1.54. Quantum-Si Incorporated has a fifty-two week low of $0.61 and a fifty-two week high of $5.77.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.16) earnings per share for the quarter, hitting the consensus estimate of ($0.16). The business had revenue of $0.59 million during the quarter, compared to analyst estimates of $1.28 million. Quantum-Si had a negative return on equity of 44.57% and a negative net margin of 3,120.14%. On average, equities research analysts anticipate that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Insider Buying and Selling at Quantum-Si

In other news, insider John S. Vieceli sold 21,923 shares of the firm’s stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total value of $35,296.03. Following the completion of the sale, the insider owned 842,586 shares of the company’s stock, valued at $1,356,563.46. This trade represents a 2.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Jeffrey Alan Hawkins sold 23,705 shares of the firm’s stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total value of $38,165.05. Following the completion of the sale, the chief executive officer directly owned 2,623,011 shares of the company’s stock, valued at approximately $4,223,047.71. This trade represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 54,252 shares of company stock valued at $87,346. Corporate insiders own 22.95% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.